What are Mission Vision & Core Values of Zoetis Company?

Zoetis Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

How does Zoetis’s purpose drive its strategy?

Mission and vision statements anchor strategy, culture, and capital allocation for Zoetis, the world’s largest stand‑alone animal health company. With 2024 revenue near $9.2–$9.5 billion and operations in 100+ countries, purpose guides R&D, market play, and talent attraction.

Zoetis’s mission, vision, and values steer pipeline choices (biologics, dermatology, pain, diagnostics), digital and genetics investments, and a customer‑first model for vets and producers. See Zoetis Porter's Five Forces Analysis.

Zoetis’ mission focuses on supporting veterinarians, producers and pet owners with medicines, vaccines, diagnostics, genetics and services to improve animal health, productivity and business outcomes worldwide.

Target customers

Veterinarians, livestock producers, pet owners, government and distributor partners across >100 countries.

Core offerings

Therapeutics, vaccines, diagnostics, genetics and biodevices spanning prevention, treatment, detection and productivity.

Market leadership

Leading franchises in dermatology, parasiticides, vaccines and diagnostics; global presence with sales in >100 countries.

Unique value

End‑to‑end platform combining therapeutics, diagnostics and data to improve animal outcomes and customer economics.

Financial scale

2024 revenue was approximately $7.7 billion, reflecting diversified streams across companion animal and livestock markets.

Practical examples

Dermatology (Apoquel, Cytopoint) improves pet welfare and clinic economics; Clarifide genomic tools boost dairy herd productivity.

Official mission: 'Zoetis is dedicated to supporting our customers and their businesses in ever better ways.' The company pairs science, innovation and customer focus to deliver measurable animal health and business benefits.

See related analysis on revenue models: Revenue Streams & Business Model of Zoetis

Zoetis SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Our vision is for our products, services and people to be the most valued by animal health customers around the world. It targets global leadership in customer value, end-to-end solutions, and trusted veterinary and producer relationships.

Customer‑centric leadership

Focuses on being most valued by customers, not just top seller; measured by trust and outcomes.

Innovation & R&D

Maintains sustained R&D spend around 7–8% of revenue (~$450–$600M annually) to extend biologics, long‑acting injectables and diagnostics.

Market position

Claims category leadership in areas like companion animal dermatology with estimated share > 45%.

Diagnostics expansion

Expanding point‑of‑care analyzers and digital cytology to deepen clinical value and recurring revenue.

Sustainability & welfare

Pursues sustainability in livestock and animal welfare initiatives as part of corporate values and ESG priorities.

Brand trust with vets

Seeks premium brand equity among veterinarians and producers through reliable products and services.

Official vision emphasizes being most valued globally; realistic given scale, product mix, R&D intensity and diagnostic growth—aligns with Zoetis mission vision core values and Zoetis company vision; see Competitors Landscape of Zoetis for context.

Zoetis PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Zoetis core values center on improving animal health and supporting the human‑animal bond through science, ethics and customer focus; these principles guide product development, field support and global operations. The company emphasizes accountable ownership, integrity, collaboration and people-driven excellence across therapeutics, diagnostics and services.

Customer First

Designs products and services around veterinary workflows and owner needs, using NPS and service benchmarks to measure impact, for example telehealth and connected devices to improve clinic efficiency.

Run It Like You Own It

Decentralized accountability in manufacturing and field sales with disciplined pricing and lifecycle strategies (e.g., patent and portfolio management for key brands) to protect margins and quality.

Always Do the Right Thing

Commitment to pharmacovigilance, transparent safety communications, antimicrobial stewardship and published ESG and animal welfare standards to meet regulatory and stakeholder expectations.

We Are One Zoetis / Colleagues Make the Difference

Cross‑functional collaboration integrates therapeutics, diagnostics and data; investment in training, DE&I and field veterinarian liaisons strengthens launch execution and customer trust globally.

Explore how Zoetis mission statement and company vision influence strategic decisions, R&D spend and market prioritization next; read more on corporate ownership and governance Owners & Shareholders of Zoetis

Values — Core Belief: Animals and people depend on each other; this guides product choices that improve the human‑animal bond (e.g., rapid pruritus relief) and One Health alignment like antimicrobial stewardship.

Purpose: To nurture our world and humankind by advancing care for animals; manifests in vaccine and prevention investment, clinic education, and programs improving livestock welfare and producer livelihoods.

Examples of Zoetis core values in practice: Customer First drives vet‑centred product design and telehealth expansion; Run It Like You Own It shows in manufacturing accountability and pricing strategy; Always Do the Right Thing is visible in pharmacovigilance and ESG reporting; We Are One Zoetis enables global launch integration; Colleagues Make the Difference appears in training, DE&I and safety targets.

Differentiation: A values system tightly coupled to veterinary economics and integrated diagnostics‑therapeutics positions the company distinctively in animal health, informing mission vision core values and investor assessments.

Zoetis Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Mission and vision statements shape strategic priorities by directing R&D, commercial focus, and global expansion decisions; they create a clear framework for resource allocation and performance targets. These guiding statements influence product pipelines, market entry, and partnerships to maximize long‑term value for customers and investors.

Zoetis mission, vision & core values — at a glance

Zoetis articulates a purpose-driven strategy to improve animal health and deliver value to customers, guided by core ethical and performance standards.

• Mission: Advance animal health through innovative medicines, vaccines, diagnostics and technologies that enhance care and productivity.
• Vision: Be the global leader in animal health, trusted for innovation, reliability and customer focus.
• Core values: Customer focus, innovation, integrity, performance and collaboration that shape behavior and decisions.
• Focus areas: Companion animal therapeutics and diagnostics plus livestock health and productivity solutions.

Strategic R&D priorities

R&D allocation favors high‑value areas such as dermatology, pain, parasiticides and biologics to meet clinician needs and sustain growth.

Diagnostics and data

Investment in VetScan, reference labs, digital cytology and AI pathology reduces diagnostic friction and increases revenue per clinic.

Market expansion

Growth emphasis in China, Brazil and EMEA livestock while scaling companion animal presence where pet spend grows >8–10% CAGR in select markets.

Commercial execution

Field teams trained on customer economics; product launches and pricing reflect mission to be 'most valued' by veterinarians and owners.

Mergers, acquisitions & partnerships

Targeted deals in diagnostics, biologics and precision livestock tech expand end‑to‑end offerings and accelerate market access.

Operational resilience

Manufacturing and supply reliability are prioritized to maintain customer trust and uphold the company purpose and values during disruptions.

Influence — Strategy alignment: Product development prioritizes dermatology, pain, parasiticides and monoclonal antibodies to deliver what customers value; diagnostics and data investments reduce clinic friction. Market expansion targets China, Brazil and EMEA livestock and companion animal markets with pet spend growing >8–10% CAGR in some regions. Examples and metrics: Dermatology leaders like Apoquel and Cytopoint contribute $billions in annual revenue with double‑digit growth; diagnostics expansion of VetScan and lab services increases revenue per clinic. Acquisitions/partnerships focus on diagnostics, biologics and precision livestock tech to broaden solutions. Operational influence: Field training, manufacturing resiliency and R&D allocation toward high‑unmet‑need indications reflect core values. Leadership voice: Management emphasizes customer value and innovation across earnings calls and investor days. Read a concise company backstory here: Brief History of Zoetis

Zoetis Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Four targeted improvements can sharpen Zoetis mission vision core values and better align strategy with measurable outcomes, sustainability, and data-driven veterinary innovation. These refinements strengthen accountability, regulatory alignment, and investor clarity while highlighting growth opportunities through technology and One Health.

Clarify measurable ambition with explicit metrics

Embed quantifiable targets (e.g., achieve top‑quartile NPS within five years, reduce disease incidence by 20% in priority conditions) in the Zoetis company vision to improve accountability and link the Zoetis mission statement to performance.

Emphasize One Health and sustainability

Expand wording to explicitly reference antimicrobial stewardship, climate resilience in livestock, and access to care—aligning Zoetis corporate values with regulator and customer priorities and reinforcing Zoetis values sustainability and animal welfare.

Future‑proof via AI, real‑world evidence, and connected care

Incorporate AI‑enabled diagnostics, real‑world evidence (RWE) and connected care into the Zoetis mission vision narrative to signal leadership in data‑driven veterinary medicine and support evidence‑based product value claims.

Set a clear 2030 growth goal

Adopt a 2030 target such as ‘lead in integrated therapeutic‑diagnostic solutions across top 10 companion conditions’ and ‘deliver quantifiable productivity and welfare gains for producers’, aligning Zoetis mission vision core values with outcome‑based industry practices.

Improvements

• Clarify measurable ambition: Add explicit outcome metrics to the vision (e.g., leadership in customer satisfaction/NPS, health outcomes, or digital adoption) to sharpen accountability.
• Emphasize One Health and sustainability: Expand mission wording to explicitly reference antimicrobial stewardship, climate resilience in livestock, and access to care—areas increasingly prioritized by regulators and customers.
• Future-proofing: Incorporate AI-enabled diagnostics, real‑world evidence, and connected care into the mission/vision narrative to signal leadership in data-driven veterinary medicine.
• Growth-oriented refinements: State a 2030 goal such as lead in integrated therapeutic-diagnostic solutions across top 10 companion conditions and deliver quantifiable productivity and welfare gains for producers, aligning with industry best practice of outcome-based visions (seen in medtech peers).

Relevant context: Zoetis reported revenue of $7.0 billion in fiscal 2024, reflecting a 6% organic revenue increase versus 2023; linking corporate targets to measurable NPS or disease‑reduction metrics would provide clearer investment and performance signals. For further background see Mission, Vision & Core Values of Zoetis

Implementation of mission and vision in corporate strategy requires aligning product development, customer engagement, and operations to measurable business outcomes. Clear KPIs, governance, and continuous feedback ensure strategic priorities translate into day‑to‑day decisions.

Zoetis: Mission, Vision & Core Values

Concise statement of purpose and guiding principles shaping strategy, culture, and stakeholder engagement.

• Zoetis mission statement: to discover, develop and deliver medicines, vaccines and diagnostic products that advance animal health and welfare.
• Zoetis company vision: to be the most valued global animal health partner, driving innovation and customer outcomes.
• Zoetis core values: Customer First, Integrity, Respect for People, Continuous Improvement and Accountability.
• These corporate values guide R&D prioritization, commercial behavior and ESG reporting.

Strategic Priorities

Focus on innovation, diagnostics, and integrated customer solutions tied to measurable herd and clinic economics.

Customer & Market Impact

Programs aim to improve adoption and outcomes; Zoetis reported 2024 revenue of approximately $8.2 billion, reflecting demand for therapeutic and diagnostic solutions.

Governance & KPIs

Portfolio committees prioritize high‑value indications; KPIs include customer satisfaction, product uptime, and regulatory compliance metrics.

ESG & Transparency

Public reporting of sustainability and innovation milestones integrates purpose and values into investor and customer communications.

Implementation

• Integrated Solutions: Bundling dermatology therapeutics with digital tools, education, and diagnostic support to increase treatment success and clinic throughput.
• Precision Livestock: Clarifide Plus genetics, sensors, and data analytics for dairy/beef herds to improve health KPIs (e.g., mastitis reduction, fertility), tying directly to customer economics.
• Diagnostics Buildout: Investment in point-of-care analyzers, reference labs, digital cytology/AI to shorten time-to-diagnosis and enhance practice efficiency.
• R&D Governance: Portfolio committees prioritize indications with highest customer value and unmet need; post-market surveillance feeds continuous improvement.

Leadership’s role: Executive communications and town halls reinforce Customer First and ownership mentality; incentive compensation linked to customer metrics, quality, growth, and compliance.

Communication: Mission/vision/values embedded in onboarding, sales training, and customer education; publicly reported ESG and innovation milestones.

Systems: Quality management and pharmacovigilance systems; Voice-of-Customer feedback loops; field medical teams translating science into practice; KPIs on supply reliability and service levels to support being most valued.

For further market context see Target Market of Zoetis